Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGAP15 antisense RNA 1 is a long non-coding RNA gene located on chromosome 2, transcribed from the antisense strand relative to the ARHGAP15 gene[5][6][7]. lncRNAs such as ARHGAP15-AS1 can be involved in the regulation of gene expression at multiple levels, including transcriptional and post-transcriptional regulation, but ARHGAP15-AS1's specific roles have not yet been described in available scientific literature or major public gene databases. There is currently no evidence that ARHGAP15-AS1 itself is a canonical therapeutic target (such as a receptor, enzyme, transporter, etc.), nor is there indication that the entry is misspelled or incorrect. It should be distinguished from ARHGAP15, which encodes a protein with well-studied regulatory functions in cell signaling and disease biology[1][2][3][4].
Not applicable; no reported drug interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGAP15 antisense RNA 1 (ARHGAP15-AS1).